Prevalence and predictors of poor outcome in children with febrile neutropaenia presenting to the emergency department.
Long, E
Babl, FE
Phillips, N
Craig, S
Zhang, M
Kochar, A
McCaskill, M
Borland, ML
Slavin, MA
Phillips, R
Lourenco, RDA
Michinaud, F
Thursky, KA
Haeusler, G
Australian PICNICC Study Group and the PREDICT Network,
- Publisher:
- Wiley
- Publication Type:
- Journal Article
- Citation:
- Emerg Med Australas, 2022, 34, (5), pp. 786-793
- Issue Date:
- 2022-10
Closed Access
Filename | Description | Size | |||
---|---|---|---|---|---|
Emerg Medicine Australasia - 2022 - Long - Prevalence and predictors of poor outcome in children with febrile neutropaenia.pdf | 315.86 kB |
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Long, E | |
dc.contributor.author | Babl, FE | |
dc.contributor.author | Phillips, N | |
dc.contributor.author | Craig, S | |
dc.contributor.author | Zhang, M | |
dc.contributor.author | Kochar, A | |
dc.contributor.author | McCaskill, M | |
dc.contributor.author | Borland, ML | |
dc.contributor.author | Slavin, MA | |
dc.contributor.author | Phillips, R | |
dc.contributor.author | Lourenco, RDA | |
dc.contributor.author | Michinaud, F | |
dc.contributor.author | Thursky, KA | |
dc.contributor.author | Haeusler, G | |
dc.contributor.author | Australian PICNICC Study Group and the PREDICT Network, | |
dc.date.accessioned | 2023-04-13T01:21:44Z | |
dc.date.available | 2022-03-27 | |
dc.date.available | 2023-04-13T01:21:44Z | |
dc.date.issued | 2022-10 | |
dc.identifier.citation | Emerg Med Australas, 2022, 34, (5), pp. 786-793 | |
dc.identifier.issn | 1742-6731 | |
dc.identifier.issn | 1742-6723 | |
dc.identifier.uri | http://hdl.handle.net/10453/169713 | |
dc.description.abstract | OBJECTIVE: Children with acquired neutropaenia due to cancer chemotherapy are at high risk of severe infection. The present study aims to describe the prevalence and predictors of poor outcomes in children with febrile neutropaenia (FN). METHODS: This is a multicentre, prospective observational study in tertiary Australian EDs. Cancer patients with FN were included. Fever was defined as a single temperature ≥38°C, and neutropaenia was defined as an absolute neutrophil count <1000/mm3 . The primary outcome was the ICU admission for organ support therapy (inotropic support, mechanical ventilation, renal replacement therapy, extracorporeal life support). Secondary outcomes were: ICU admission, ICU length of stay (LOS) ≥3 days, proven or probable bacterial infection, hospital LOS ≥7 days and 28-day mortality. Initial vital signs, biomarkers (including lactate) and clinical sepsis scores, including Systemic Inflammatory Response Syndrome, quick Sequential Organ Failure Assessment and quick Paediatric Logistic Organ Dysfunction-2 were evaluated as predictors of poor outcomes. RESULTS: Between December 2016 and January 2018, 2124 episodes of fever in children with cancer were screened, 547 episodes in 334 children met inclusion criteria. Four episodes resulted in ICU admission for organ support therapy, nine episodes required ICU admission, ICU LOS was ≥3 days in four, hospital LOS was ≥7 days in 153 and two patients died within 28 days. Vital signs, blood tests and clinical sepsis scores, including Systemic Inflammatory Response Syndrome, quick Sequential Organ Failure Assessment and quick Paediatric Logistic Organ Dysfunction-2, performed poorly as predictors of these outcomes (area under the receiver operating characteristic curve <0.6). CONCLUSIONS: Very few patients with FN required ICU-level care. Vital signs, biomarkers and clinical sepsis scores for the prediction of poor outcomes are of limited utility in children with FN. | |
dc.format | Print-Electronic | |
dc.language | eng | |
dc.publisher | Wiley | |
dc.relation.ispartof | Emerg Med Australas | |
dc.relation.isbasedon | 10.1111/1742-6723.13978 | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | 1103 Clinical Sciences, 1117 Public Health and Health Services | |
dc.subject.classification | Emergency & Critical Care Medicine | |
dc.subject.mesh | Australia | |
dc.subject.mesh | Biomarkers | |
dc.subject.mesh | Child | |
dc.subject.mesh | Emergency Service, Hospital | |
dc.subject.mesh | Febrile Neutropenia | |
dc.subject.mesh | Hospital Mortality | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Intensive Care Units | |
dc.subject.mesh | Lactates | |
dc.subject.mesh | Multiple Organ Failure | |
dc.subject.mesh | Organ Dysfunction Scores | |
dc.subject.mesh | Prevalence | |
dc.subject.mesh | Prognosis | |
dc.subject.mesh | ROC Curve | |
dc.subject.mesh | Retrospective Studies | |
dc.subject.mesh | Sepsis | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Sepsis | |
dc.subject.mesh | Multiple Organ Failure | |
dc.subject.mesh | Lactates | |
dc.subject.mesh | Prognosis | |
dc.subject.mesh | Prevalence | |
dc.subject.mesh | Hospital Mortality | |
dc.subject.mesh | Retrospective Studies | |
dc.subject.mesh | ROC Curve | |
dc.subject.mesh | Child | |
dc.subject.mesh | Emergency Service, Hospital | |
dc.subject.mesh | Intensive Care Units | |
dc.subject.mesh | Australia | |
dc.subject.mesh | Organ Dysfunction Scores | |
dc.subject.mesh | Febrile Neutropenia | |
dc.subject.mesh | Biomarkers | |
dc.subject.mesh | Australia | |
dc.subject.mesh | Biomarkers | |
dc.subject.mesh | Child | |
dc.subject.mesh | Emergency Service, Hospital | |
dc.subject.mesh | Febrile Neutropenia | |
dc.subject.mesh | Hospital Mortality | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Intensive Care Units | |
dc.subject.mesh | Lactates | |
dc.subject.mesh | Multiple Organ Failure | |
dc.subject.mesh | Organ Dysfunction Scores | |
dc.subject.mesh | Prevalence | |
dc.subject.mesh | Prognosis | |
dc.subject.mesh | ROC Curve | |
dc.subject.mesh | Retrospective Studies | |
dc.subject.mesh | Sepsis | |
dc.title | Prevalence and predictors of poor outcome in children with febrile neutropaenia presenting to the emergency department. | |
dc.type | Journal Article | |
utslib.citation.volume | 34 | |
utslib.location.activity | Australia | |
utslib.for | 1103 Clinical Sciences | |
utslib.for | 1117 Public Health and Health Services | |
pubs.organisational-group | /University of Technology Sydney | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Health | |
pubs.organisational-group | /University of Technology Sydney/Strength - CHERE - Centre for Health Economics Research and Evaluation | |
pubs.organisational-group | /University of Technology Sydney/Strength - CHT - Health Technologies | |
pubs.organisational-group | /University of Technology Sydney/Centre for Health Technologies (CHT) | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Health/Centre for Health Economics Research and Evaluation | |
utslib.copyright.status | closed_access | * |
dc.date.updated | 2023-04-13T01:21:42Z | |
pubs.issue | 5 | |
pubs.publication-status | Published | |
pubs.volume | 34 | |
utslib.citation.issue | 5 |
Abstract:
OBJECTIVE: Children with acquired neutropaenia due to cancer chemotherapy are at high risk of severe infection. The present study aims to describe the prevalence and predictors of poor outcomes in children with febrile neutropaenia (FN). METHODS: This is a multicentre, prospective observational study in tertiary Australian EDs. Cancer patients with FN were included. Fever was defined as a single temperature ≥38°C, and neutropaenia was defined as an absolute neutrophil count <1000/mm3 . The primary outcome was the ICU admission for organ support therapy (inotropic support, mechanical ventilation, renal replacement therapy, extracorporeal life support). Secondary outcomes were: ICU admission, ICU length of stay (LOS) ≥3 days, proven or probable bacterial infection, hospital LOS ≥7 days and 28-day mortality. Initial vital signs, biomarkers (including lactate) and clinical sepsis scores, including Systemic Inflammatory Response Syndrome, quick Sequential Organ Failure Assessment and quick Paediatric Logistic Organ Dysfunction-2 were evaluated as predictors of poor outcomes. RESULTS: Between December 2016 and January 2018, 2124 episodes of fever in children with cancer were screened, 547 episodes in 334 children met inclusion criteria. Four episodes resulted in ICU admission for organ support therapy, nine episodes required ICU admission, ICU LOS was ≥3 days in four, hospital LOS was ≥7 days in 153 and two patients died within 28 days. Vital signs, blood tests and clinical sepsis scores, including Systemic Inflammatory Response Syndrome, quick Sequential Organ Failure Assessment and quick Paediatric Logistic Organ Dysfunction-2, performed poorly as predictors of these outcomes (area under the receiver operating characteristic curve <0.6). CONCLUSIONS: Very few patients with FN required ICU-level care. Vital signs, biomarkers and clinical sepsis scores for the prediction of poor outcomes are of limited utility in children with FN.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph